Key Dates

Related Announcements

PAR-18-746 -  NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

PAR-20-249 - NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

This notice is to inform applicants that the PAR-18-746, NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional) was inadvertently closed and has now been re-opened for the remaining AIDS date only (August 28, 2020) and will expire on August 29, 2020. Future applications should be submitted using the new FOA, PAR-20-249, NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional).

All other aspects of PAR-18-746 remain unchanged.

Inquiries

Please direct all inquiries to:

Aria Davis Crump, Sc.D.
National Institute on Drug Abuse (NIDA)
Division of Epidemiology, Services and Prevention Research
Telephone: 301-435-0881
Email: acrump@nida.nih.gov

Ann Anderson, M.P.H., M.D.
National Institute on Drug Abuse (NIDA)
Division of Therapeutics and Medical Consequences < br> Telephone: 301-827-5916
Email: aa135m@nih.gov

Yu (Woody) Lin, M.D., Ph.D.
National Institute on Drug Abuse (NIDA)
Division of Neuroscience and Behavior
Telephone: 301-435-1318
Email: ylin1@mail.nih.gov

Albert Avila, Ph.D.
National Institute on Drug Abuse (NIDA)
Office of Research Training, Diversity, and Disparities (ORTDD)
Telephone: 301.496.8804
Email: NIDA_Training@nida.nih.gov